Fujitsu Components America | Fujitsu Computer Products of America | Fujitsu Consulting | Fujitsu Interconnect Technologies | Fujitsu Microelectronics America | Fujitsu Network Communications | Fujitsu Transaction Solutions | BioSciences Group |
2005 Press Releases by Subsidiary
BioSciences Group
- 13 December 2005 San Francisco, CA
- The BioSciences Group of Fujitsu Announces CELLINJECTOR Evaluation Project with Whitehead Institute for High-Throughput Cell-Based
Research
San Francisco, CA, December 13, 2005 – At the American Society for Cell Biology (ASCB) Annual Meeting today, the BioSciences Group of Fujitsu Computer Systems announced a new evaluation project with Whitehead Institute for Biomedical Research, focusing on high-throughput cell-based research.
- 10 August 2005 Westwood, Massachusetts
- The BioSciences Group of Fujitsu Introduces CELLINJECTOR™ Automated Microinjection System
Westwood, Massachusetts, August 10, 2005 – The BioSciences Group of Fujitsu Computer Systems today announced that it has developed an automated microinjection system called CELLINJECTOR, to enable very large-scale direct injection of agents through cell membranes for biochemical research.
- 11 July 2005 Westwood, Massachusetts
- The BioSciences Group of Fujitsu Unveils New in silico Technique for Enhanced ADME/Tox Predictions
Westwood, Massachusetts, July 11, 2005 – The BioSciences Group of Fujitsu Computer Systems today unveiled a new technique for generating enhanced predictions for ADME/Tox research, consisting of a unique docking-based approach combined with off-the-shelf and purpose-built technologies, to develop viable and effective predictive models. The new approach was developed with a commercial collaborator focusing on drug-resistant infectious diseases and cancer.
- 18 May 2005 Bio-IT World Expo - Boston, Massachusetts
- The BioSciences Group of Fujitsu Offers 'High Throughput Docking' to Overcome Challenges of High Throughput Screening
Bio-IT World Expo - Boston, Massachusetts, May 18, 2005 – At Bio-IT World Expo in Boston, The BioSciences Group of Fujitsu Computer Systems demonstrated its offerings in "High Throughput Docking," (HT Docking) as a means to make High Throughput Screening (HTS) more productive and effective in drug discovery.
- 14 April 2005 Sunnyvale, CA
- Fujitsu Transfers BioSciences Group to Provide Enhanced Service and Support to Life Sciences Market
Sunnyvale, CA, April 14, 2005 – "We are very pleased to have The BioSciences Group join Fujitsu Computer Systems," said Toshio Morohoshi, President & CEO, Fujitsu Computer Systems Corporation. "We see this transfer as the ideal integration of expertise and services. The BioSciences Group gains expertise in enterprise-scale solutions, and provides life sciences-specific technologies and services in order to introduce Fujitsu offerings in the North American life sciences market."
- 22 February 2005 Westwood, MA
- Fujitsu America BioSciences Group Announces Agreement with NeurAxon for BioMedCAChe™ Automated Docking Software with
ActiveSite™ Module
Westwood, MA, February 22, 2005 – The BioSciences Group of Fujitsu America, Inc., a worldwide leader in providing innovative and reliable solutions to experimental scientists, today announced a licensing agreement for its BioMedCAChe suite of automated docking and molecular modeling software with NeurAxon, Inc., a Canadian company specializing in drug development for pain and central nervous system (CNS) disorders. The deal includes provision of the BioSciences Group’s ActiveSite module for designing effective small molecule inhibitors of protein targets.
- 11 January 2005 Westwood, MA
- Fujitsu America BioSciences Group Announces Global Licensing Deal with GPC Biotech AG for BioMedCAChe™ Automated Docking
Software
Westwood, MA, January 11, 2005 – The BioSciences Group of Fujitsu America, Inc., a worldwide leader in providing innovative and reliable solutions to experimental scientists, today announced a global licensing agreement with GPC Biotech AG, a global cancer drug discovery and development company, for Fujitsu's BioMedCAChe suite of automated docking and molecular modeling software. GPC Biotech will implement BioMedCAChe in its Waltham, Massachusetts and Martinsried/Munich, Germany sites.
